Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Champions Oncology Q2 EPS $(0.15) Down From $0.01 YoY, Sales $11.60M Down From $14.28M YoY

Author: Benzinga Newsdesk | December 12, 2023 05:04pm

Champions Oncology (NASDAQ:CSBR) reported quarterly losses of $(0.15) per share. This is a 1600 percent decrease over earnings of $0.01 per share from the same period last year. The company reported $11.60 million in sales this quarter. This is a 18.77 percent decrease over sales of $14.28 million the same period last year.

Posted In: CSBR